Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

被引:7
|
作者
AmraneDjedidi, Rania [1 ]
Rousseau, Aurelie [2 ]
Larsen, Annette K. [1 ]
Elalamy, Ismail [1 ,3 ]
Van Dreden, Patrick [2 ]
Gerotziafas, Grigoris T. [1 ,3 ]
机构
[1] Sorbonne Univ, Res Grp Canc Haemostasis & Angiogenesis, INSERM U938, Ctr Rech St Antoine,Inst Univ Cancerol,Fac Med, Paris, France
[2] Diagnost Stago, Dept Clin Res, Gennevilliers, France
[3] Sorbonne Univ, Hop Univ Est Parisien, St Antoine Hosp, AP HP,Dept Hematol & Cell Therapy, Paris, France
关键词
Endothelial cells; Thrombin generation; Extracellular vesicles; Tissue factor; Cancer associated thrombosis; TISSUE FACTOR ACTIVITY; MESSENGER-RNA; TUMOR-CELLS; MICROPARTICLES; COMMUNICATION; EXPRESSION; RISK;
D O I
10.1016/j.thromres.2019.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endothelium could be a potential target of cancer cell derived extracellular vesicles (CaCe-dEV). We investigated in vitro the effect of CaCe-dEV on the hemostatic balance of endothelial cells. Extracellular vesicles released from pancreas adenocarcinoma cells (BXPC3) or human breast cancer cells (MCF7) were isolated by differential centrifugation. Human umbilical vein endothelial cells (HUVEC) were cultured for 72 h in the presence or absence of CaCe-dEV. Subsequently, they were washed and re-cultivated over three cycles to get daughter cell generations (DG) which were not exposed to CaCe-dEV. Thrombin generation of normal platelet poor plasma (PPP) added in wells carrying HUVEC was assessed by the Calibrated Automated Thrombogram (R). Tissue factor activity (TFa) and procoagulant phospholipid clotting time were assessed. Some traces of TFa were displayed by non-exposed HUVEC (0.18 +/- 0.03 pM) and their EVs (1.2 +/- 1.0 pM). Non-exposed HUVEC did not induce any detectable thrombin generation. BXPC3-dEV displayed significantly higher TFa as compared to MCF7-dEV (45 +/- 5 pM versus 4.6 +/- 2.3pM respectively; p < 0.05). HUVEC exposed to CaCe-dEV enhanced thrombin generation. BXPC3-dEV induced significantly higher thrombin generation as compared to those exposed to MCF7-dEV. The procoagulant properties of HUVEC, acquired upon exposure to CaCe-dEV were transferred to DG. In conclusion, CaCe-dEV lead to a procoagulant shift of endothelial cells which, upon exposure, display TFa and enhance thrombin generation which is transferred to DG of HUVEC. The potency of CaCe-dEV to induce procoagulant shift of HUVEC depends on the histological type of the cancer cells. The procoagulant shift of endothelial cells which is transferable to DG could be an additional mechanism - together with cancer-induced blood hypercoagulability - in the pathogenesis of cancer associated thrombosis.
引用
收藏
页码:170 / 179
页数:10
相关论文
共 50 条
  • [1] Modelisation of the procoagulant properties of adenocarcinoma pancreatic cells (BXPC3) and breast cancer cells (MCF7) and analysis of their specific interactions with the coagulation system
    Rousseau, A.
    Dreden, P., V
    Gerotziafas, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 302 - 303
  • [2] Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7
    Gerotziafas, Grigoris T.
    Galea, Vassiliki
    Mbemba, Elisabeth
    Khaterchi, Amir
    Sassi, Mouna
    Baccouche, Hela
    Prengel, Claudie
    van Dreden, Patrick
    Hatmi, Mohamed
    Bernaudin, Jean Francois
    Elalamy, Ismail
    THROMBOSIS RESEARCH, 2012, 129 (06) : 779 - 786
  • [3] Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin
    Rousseau, Aurelie
    Van Dreden, Patrick
    Mbemba, Elisabeth
    Elalamy, Ismail
    Larsen, Annette
    Gerotziafas, Grigoris T.
    THROMBOSIS RESEARCH, 2015, 136 (06) : 1273 - 1279
  • [4] Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin
    Rousseau, A.
    Van Dreden, P.
    Elalamy, I
    Gerotziafas, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 263 - 263
  • [5] Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity
    Osorio-Mendez, Jhon Jairo
    Gomez-Grosso, Luis Alberto
    Montoya-Ortiz, Gladis
    Novoa-Herran, Susana
    Dominguez-Romero, Yohana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [6] Effect of punicic acid on MCF7 breast cancer cells
    Gbayisomore, Oluwafemi
    Klausner, Hannah
    Phelan, Shelley A.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] The Effect of Cholesterol in MCF7 Human Breast Cancer Cells
    Albi, Elisabetta
    Mandarano, Martina
    Cataldi, Samuela
    Ceccarini, Maria Rachele
    Fiorani, Federico
    Beccari, Tommaso
    Sidoni, Angelo
    Codini, Michela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [8] Cancer-Derived Small Extracellular Vesicles Affect Vascular Endothelial Cells and Promote Adhesiveness of Pancreatic Cancer Cells
    Furuke, Hirotaka
    Arita, Tomohiro
    Konishi, Hirotaka
    Kataoka, Satoshi
    Shibamoto, Jun
    Takabatake, Kazuya
    Takaki, Wataru
    Shimizu, Hiroki
    Yamamoto, Yusuke
    Morimura, Ryo
    Komatsu, Shuhei
    Shiozaki, Atsushi
    Ikoma, Hisashi
    Otsuji, Eigo
    PANCREAS, 2024, 53 (07) : e603 - e610
  • [9] Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells
    An, Jeongshin
    Kim, Jong Bin
    Yang, Eun Yeol
    Kim, Hye Ok
    Lee, Won-Hee
    Yang, Jinho
    Kwon, Hyungju
    Paik, Nam Sun
    Lim, Woosung
    Kim, Yoon-Keun
    Moon, Byung-In
    MEDICINE, 2021, 100 (18) : E25835
  • [10] Insulin stimulated MCF7 breast cancer cells: Proteome dataset
    Sarvaiya, Hetal A.
    Lazar, Iulia M.
    DATA IN BRIEF, 2016, 9 : 579 - 584